LORI, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 880
NA - Nord America 876
AS - Asia 177
AF - Africa 7
Totale 1.940
Nazione #
US - Stati Uniti d'America 875
PL - Polonia 286
RU - Federazione Russa 281
IT - Italia 140
IE - Irlanda 78
SE - Svezia 54
HK - Hong Kong 47
CN - Cina 45
SG - Singapore 36
JO - Giordania 25
VN - Vietnam 12
DE - Germania 11
IN - India 8
MK - Macedonia 8
CI - Costa d'Avorio 6
GB - Regno Unito 6
FI - Finlandia 5
PH - Filippine 3
AL - Albania 2
FR - Francia 2
UA - Ucraina 2
BA - Bosnia-Erzegovina 1
CA - Canada 1
CH - Svizzera 1
ES - Italia 1
NL - Olanda 1
RS - Serbia 1
TR - Turchia 1
UG - Uganda 1
Totale 1.940
Città #
Warsaw 286
Fairfield 156
Dublin 78
Chandler 73
Ashburn 72
Seattle 66
Houston 65
Florence 64
Woodbridge 61
Santa Clara 55
Cambridge 51
Wilmington 39
Altamura 32
Hong Kong 32
Lawrence 32
Singapore 30
Moscow 25
Ann Arbor 22
Princeton 17
Beijing 15
Shanghai 15
Boston 12
San Diego 11
Dong Ket 10
Buffalo 9
Medford 7
Abidjan 6
Kent 6
Mumbai 5
Redwood City 5
Falls Church 4
Los Angeles 4
Helsinki 3
London 3
Milan 3
Ohrid 3
Phoenix 3
Renton 3
Andover 2
Boardman 2
Lappeenranta 2
Napoli 2
Nürnberg 2
Redmond 2
Rennes 2
Rome 2
Serra 2
Siena 2
Silea 2
Amsterdam 1
Anguillara Sabazia 1
Bagno A Ripoli 1
Barcelona 1
Belgrade 1
Berlin 1
Bern 1
Brentford 1
Cagayan de Oro 1
Castelliri 1
Clifton 1
Dearborn 1
Eboli 1
Haikou 1
Hillsboro 1
Istanbul 1
Laurel 1
Makati City 1
Nanjing 1
Norwalk 1
Perugia 1
Portland 1
Pune 1
Sarajevo 1
Scandicci 1
Shaoxing 1
Skopje 1
Southwark 1
Toronto 1
Washington 1
Totale 1.435
Nome #
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. 193
LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy 169
Honey extracts inhibit PTP1B, upregulate insulin receptor expression, and enhance glucose uptake in human HepG2 cells 167
LMW-PTP modulates glucose metabolism in cancer cells 132
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 120
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 117
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 115
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 111
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 101
Fatty acids regulate the biology of cholangiocarcinoma cells 100
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 98
Morin-dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW-PTP) restores sensitivity to apoptosis during colon carcinogenesis: Studies in vitro and in vivo, in an Apc-driven model of colon cancer 94
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 88
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD 84
Role of chemokines in the biology of cholangiocarcinoma 83
Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study 80
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 53
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer 36
Metabolic challengers selecting tumor-persistent cells 30
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 10
The Neolignan Honokiol and Its Synthetic Derivative Honokiol Hexafluoro Reduce Neuroinflammation and Cellular Senescence in Microglia Cells 7
Totale 1.988
Categoria #
all - tutte 6.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 0 0 0 47 41 39 48 45 35 38 11
2020/2021359 21 28 34 35 18 30 30 39 34 49 21 20
2021/2022166 20 8 3 7 3 22 2 14 15 12 18 42
2022/2023379 29 87 23 15 20 59 47 35 50 1 12 1
2023/2024151 5 16 19 4 7 12 7 44 6 15 11 5
2024/2025403 36 88 50 177 52 0 0 0 0 0 0 0
Totale 1.988